Assessing the benefit-harm balance at the bedside
- 1 July 2004
- Vol. 329 (7456) , 7-8
- https://doi.org/10.1136/bmj.329.7456.7
Abstract
We need pragmatic ways of using the best available informationThis publication has 10 references indexed in Scilit:
- Benefits and harms of drug treatmentsBMJ, 2004
- Joining the DoTS: new approach to classifying adverse drug reactionsBMJ, 2003
- Aspirin for the prevention of cardiovascular disease: calculating benefit and harm in the individual patientPublished by Wiley ,2003
- Efficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trialsBMJ, 2002
- Provision of information about drug side-effects to patientsThe Lancet, 2002
- Drug safety--important to us all!2001
- Reporting of adverse drug reactions in randomised controlled trials – a systematic surveyBMC Clinical Pharmacology, 2001
- Assessment of therapeutic safety in systematic reviews: literature reviewBMJ, 2001
- Drug companies should report side effects in terms of frequencyBMJ, 1996
- An evidence based approach to individualising treatmentBMJ, 1995